War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges

War in Ukraine: Current and future impacts on the Romanian cancer care system

Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients

Natural killer cells complexed with a bispecific antibody may provide new treatment option for patients with advanced lymphoma

Intratumoral BO-112 with pembrolizumab shows benefit in advanced melanoma refractory to anti-PD-1 therapy

Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid tumours

Immune gene signatures for predicting response to neoadjuvant chemoimmunotherapy in NSCLC

Atezolizumab with or without radiotherapy for advanced squamous cell carcinoma of the penis

KEYNOTE 564 update: Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma

Durvalumab with olapirib shows no PFS improvement for platinum-ineligible bladder cancer

OncoAlert and ecancer weekly round up for February 7th - 13th, 2022

Update on the new EUSOMA quality indicators for breast cancer